Testing a drug and exercise for heart and muscle fat in diabetes
Part of Hormones & metabolism clinical trials.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 75 years old
- You have type 2 diabetes diagnosed within the last 10 years and are not on insulin
- Your HbA1c (a measure of blood sugar) is 7% or higher
- You get less than 150 minutes of moderate-to-vigorous activity per week (like brisk walking or cycling)
- Your body mass index (BMI) is 27 or higher, and you weigh less than 140 kg (about 308 pounds)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This trial tests whether semaglutide (a diabetes drug) can help protect kidney function in people with type 2 diabetes who already have mild to moderate kidney damage. You will take semaglutide or a placebo and have regular kidney function tests.
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
This trial studies whether the drug semaglutide can help people with heart failure who are overweight. It aims to see if the drug improves heart function and symptoms.
This study tests if a daily semaglutide pill can reduce harmful fat around the heart in people with type 2 diabetes who had a heart attack 2 to 9 months ago. It aims to see if this treatment can improve heart health.
Hear when a new Diabetes Mellitus Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.